Investor

The rounds this investor is named on, who it invests beside, and where it shows up.

4BIO Capital: led 1 round · Fireround

Aptadir Therapeutics[ LEAD ]

A preclinical biotech company developing a new class of RNA therapeutics

Seed$45.5M2026-09-295

Company	Round	Amount	Announced	Role
Aptadir Therapeutics A preclinical biotech company developing a new class of RNA therapeutics	Seed Verified against 5 sources	$45.5M	2026-09-29	[ LEAD ]